Cellworks Biosimulation Platform and computational biology omics model (CBM) is advancing Personalized Oncology with patient-specific cancer therapy predictions. Cellworks goes beyond the current population-based biomarker therapy pairings by interpreting complete mutational downstream effects of a patient’s gene network to deliver precise, transparent therapy predictions. Cellworks Therapy Response Index (TRI) empowers physicians to provide personalized therapy selection, avoid unnecessary treatments, and improve patient outcomes. Go to www.cellworks.life to join myCare clinical trials.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes